C/EBPa-mediated activation of microRNAs 34a and 223 inhibits lef1 expression to achieve efficient reprogramming into macrophages

Molecular and Cellular Biology

Volumn 34, Issue 6, 2014, Pages 1145-1157

  Rodriguez Ubreva, Javier ^a   Ciudad, Laura ^a   van Oevelen, Chris ^b   Parra, Maribel ^a   Graf, Thomas ^b,c   Ballestar, Esteban ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIGENS, CD19; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; CCAAT-ENHANCER-BINDING PROTEINS; CELL TRANSDIFFERENTIATION; DOWN-REGULATION; IKAROS TRANSCRIPTION FACTOR; LYMPHOID ENHANCER-BINDING FACTOR 1; MACROPHAGES; MICE; MICRORNAS; PRECURSOR CELLS, B-LYMPHOID; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84894251528     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01487-13     Document Type: Article

References (41)

1. Ambros V. 2001. microRNAs: tiny regulators with great potential. Cell 107:823-826. http://dx.doi.org/10.1016/S0092-8674(01)00616-X.
2. Kulessa H, Frampton J, Graf T. 1995. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev. 9:1250-1262. http://dx.doi.org/10.1101/gad.9.10.1250.
3. Nerlov C, Graf T. 1998. PU. 1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12:2403-2412. http://dx.doi.org/10.1101/gad.12.15.2403.
4. Xie H, Ye M, Feng R, Graf T. 2004. Stepwise reprogramming of B cells into macrophages. Cell 117:663-676. http://dx.doi.org/10.1016/S0092-8674(04)00419-2.
5. Ji H, Ehrlich LI, Seita J, Murakami P, Doi A, Lindau P, Lee H, Aryee MJ, Irizarry RA, Kim K, Rossi DJ, Inlay MA, Serwold T, Karsunky H, Ho L, Daley GQ, Weissman IL, Feinberg AP. 2010. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 467:338-342. http://dx.doi.org/10.1038/nature09367.
6. Bussmann LH, Schubert A, Vu Manh TP, De Andres L, Desbordes SC, Parra M, Zimmermann T, Rapino F, Rodriguez-Ubreva J, Ballestar E, Graf T. 2009. A robust and highly efficient immune cell reprogramming system. Cell Stem Cell 5:554-566. http://dx.doi.org/10.1016/j.stem.2009.10.004.
7. Heath V, Suh HC, Holman M, Renn K, Gooya JM, Parkin S, Klarmann KD, Ortiz M, Johnson P, Keller J. 2004. C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood 104:1639-1647. http://dx.doi.org/10.1182/blood-2003-11-3963.
8. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. 1997. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94:569-574. http://dx.doi.org/10.1073/pnas.94.2.569.
9. Di Tullio A, Vu Manh TP, Schubert A, Mansson R, Graf T. 2011. CCAAT/enhancer binding protein alpha (C/EBP(alpha))-induced transdifferentiation of pre-B cells into macrophages involves no overt retrodifferentiation. Proc. Natl. Acad. Sci. U. S. A. 108:17016-17021. http://dx.doi.org/10.1073/pnas.1112169108.
10. Nutt SL, Morrison AM, Dorfler P, Rolink A, Busslinger M. 1998. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17:2319-2333. http://dx.doi.org/10.1093/emboj/17.8.2319.
11. Reya T, O'Riordan M, Okamura R, Devaney E, Willert K, Nusse R, Grosschedl R. 2000. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13:15-24. http://dx.doi.org/10.1016/S1074-7613(00)00004-2.
12. Skokowa J, Welte K. 2009. Dysregulation of myeloid-specific transcription factors in congenital neutropenia. Ann. N. Y. Acad. Sci. 1176:94-100. http://dx.doi.org/10.1111/j.1749-6632.2009.04963.x.
13. Travis A, Amsterdam A, Belanger C, Grosschedl R. 1991. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]. Genes Dev. 5:880-894. http://dx.doi.org/10.1101/gad.5.5.880.
14. Rodríguez-Ubreva J, Ciudad L, Gómez-Cabrero D, Parra M, Bussmann LH, di Tullio A, Kallin EM, Tegnér J, Graf T, Ballestar E. 2012. Pre-B cell to macrophage transdifferentiation without significant promoter DNA methylation changes. Nucleic Acids Res. 40:1954-1968. http://dx.doi.org/10.1093/nar/gkr1015.
15. Kallin EM, Rodriguez-Ubreva J, Christensen J, Cimmino L, Aifantis I, Helin K, Ballestar E, Graf T. 2012. Tet2 facilitates the derepression of myeloid target genes during CEBPalpha-induced transdifferentiation of pre-B cells. Mol. Cell 48:266-276. http://dx.doi.org/10.1016/j.molcel.2012.08.007.
16. Alessandrini A, Pierce JH, Baltimore D, Desiderio SV. 1987. Continuing rearrangement of immunoglobulin and T-cell receptor genes in a Ha-rastransformed lymphoid progenitor cell line. Proc. Natl. Acad. Sci. U. S. A. 84:1799-1803. http://dx.doi.org/10.1073/pnas.84.7.1799.
17. Raschke WC, Baird S, Ralph P, Nakoinz I. 1978. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261-267. http://dx.doi.org/10.1016/0092-8674(78)90101-0.
18. Larionov A, Krause A, Miller W. 2005. A standard curve based method for relative real time PCR data processing.BMCBioinformatics 6:62. http://dx.doi.org/10.1186/1471-2105-6-62.
19. Nicol JW, Helt GA, Blanchard SG, Jr, Raja A, Loraine AE. 2009. The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets. Bioinformatics 25:2730-2731. http://dx.doi.org/10.1093/bioinformatics/btp472.
20. Pospisil V, Vargova K, Kokavec J, Rybarova J, Savvulidi F, Jonasova A, Necas E, Zavadil J, Laslo P, Stopka T. 2011. Epigenetic silencing of the oncogenic miR-17-92 cluster during PU. 1-directed macrophage differentiation. EMBO J. 30:4450-4464. http://dx.doi.org/10.1038/emboj.2011.317.
21. Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, Nervi C, Bozzoni I. 2005. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123:819-831. http://dx.doi.org/10.1016/j.cell.2005.09.023.
22. Fukao T, Fukuda Y, Kiga K, Sharif J, Hino K, Enomoto Y, Kawamura A, Nakamura K, Takeuchi T, Tanabe M. 2007. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129:617-631. http://dx.doi.org/10.1016/j.cell.2007.02.048.
23. Pulikkan JA, Peramangalam PS, Dengler V, Ho PA, Preudhomme C, Meshinchi S, Christopeit M, Nibourel O, Muller-Tidow C, Bohlander SK, Tenen DG, Behre G. 2010. C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood 116:5638-5649. http://dx.doi.org/10.1182/blood-2010-04-281600.
24. Rao DS, O'Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D. 2010. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 33:48-59. http://dx.doi.org/10.1016/j.immuni.2010.06.013.
25. Velu CS, Baktula AM, Grimes HL. 2009. Gfi1 regulates miR-21 and miR-196b to control myelopoiesis. Blood 113:4720-4728. http://dx.doi.org/10.1182/blood-2008-11-190215.
26. Choong ML, Yang HH, McNiece I. 2007. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp. Hematol. 35:551-564. http://dx.doi.org/10.1016/j.exphem.2006.12.002.
27. Song SJ, Ito K, Ala U, Kats L, Webster K, Sun SM, Jongen-Lavrencic M, Manova-Todorova K, Teruya-Feldstein J, Avigan DE, Delwel R, Pandolfi PP. 2013. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 13:87-101. http://dx.doi.org/10.1016/j.stem.2013.06.003.
28. Yang GH, Wang F, Yu J, Wang XS, Yuan JY, Zhang JW. 2009. Micro-RNAs are involved in erythroid differentiation control. J. Cell. Biochem. 107:548-556. http://dx.doi.org/10.1002/jcb.22156.
29. Dweep H, Sticht C, Pandey P, Gretz N. 2011. miRWalk-database: prediction of possiblemi RNA binding sites by "walking" the genes of three genomes. J. Biomed. Inform. 44:839-847. http://dx.doi.org/10.1016/j.jbi.2011.05.002.
30. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20. http://dx.doi.org/10.1016/j.cell.2004.12.035.
31. Wang X. 2008. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14:1012-1017. http://dx.doi.org/10.1261/rna.965408.
32. Skokowa J, Cario G, Uenalan M, Schambach A, Germeshausen M, Battmer K, Zeidler C, Lehmann U, Eder M, Baum C, Grosschedl R, Stanulla M, Scherr M, Welte K. 2006. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat.Med.12:1191-1197. http://dx.doi.org/10.1038/nm1474.
33. Skokowa J, Klimiankou M, Klimenkova O, Lan D, Gupta K, Hussein K, Carrizosa E, Kusnetsova I, Li Z, Sustmann C, Ganser A, Zeidler C, Kreipe HH, Burkhardt J, Grosschedl R, Welte K. 2012. Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSFtriggered granulopoiesis. Nat. Med. 18:1550-1559. http://dx.doi.org/10.1038/nm.2958.
34. Zardo G, Ciolfi A, Vian L, Starnes LM, Billi M, Racanicchi S, Maresca C, Fazi F, Travaglini L, Noguera N, Mancini M, Nanni M, Cimino G, Lo-Coco F, Grignani F, Nervi C. 2012. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood 119:4034-4046. http://dx.doi.org/10.1182/blood-2011-08-371344.
35. Lu TX, Lim EJ, Besse JA, Itskovich S, Plassard AJ, Fulkerson PC, Aronow BJ, Rothenberg ME. 2013. MiR-223 deficiency increases eosinophil progenitor proliferation. J. Immunol. 190:1576-1582. http://dx.doi.org/10.4049/jimmunol.1202897.
36. Zhuang G, Meng C, Guo X, Cheruku PS, Shi L, Xu H, Li H, Wang G, Evans AR, Safe S, Wu C, Zhou B. 2012. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 125:2892-2903. http://dx.doi.org/10.1161/CIRCULATIONAHA.111.087817.
37. Navarro F, Gutman D, Meire E, Caceres M, Rigoutsos I, Bentwich Z, Lieberman J. 2009. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 114:2181-2192. http://dx.doi.org/10.1182/blood-2009-02-205062.
38. Kee BL, Murre C. 2001. Transcription factor regulation of B lineage commitment. Curr. Opin. Immunol. 13:180-185. http://dx.doi.org/10.1016/S0952-7915(00)00202-8.
39. Gutierrez A, Jr, Tschumper RC, Wu X, Shanafelt TD, Eckel-Passow J, Huddleston PM, III, Slager SL, Kay NE, Jelinek DF. 2010. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood 116:2975-2983. http://dx.doi.org/10.1182/blood-2010-02-269878.
40. Yu S, Zhou X, Steinke FC, Liu C, Chen SC, Zagorodna O, Jing X, Yokota Y, Meyerholz DK, Mullighan CG, Knudson CM, Zhao DM, Xue HH. 2012. The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy. Immunity 37:813-826. http://dx.doi.org/10.1016/j.immuni.2012.08.009.
41. Dahl R, Walsh JC, Lancki D, Laslo P, Iyer SR, Singh H, Simon MC. 2003. Regulation of macrophage and neutrophil cell fates by the PU. 1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat. Immunol. 4:1029-1036. http://dx.doi.org/10.1038/ni973.